Search   
MSDS  : Pyrrolo(2,3-b)indole, 1,2,3,3a,8,8a-hexahydro-5-hydroxy-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, sulfate (2:1)
CAS  : 64-47-1
SYNONYMS  : * Eserine sulfate * Eserine sulphate * Physostigmine hemisulfate * Physostigmine SO4 * Physostigmine sulfate * Physostigmine sulphate
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : UY8585000
CHEMICAL NAME : Pyrrolo(2,3-b)indole,
1,2,3,3a,8,8a-hexahydro-5-hydroxy-1,3a,8-trimethyl-,
methylcarbamate (ester), (3aS-cis)-, sulfate (2:1)
CAS REGISTRY NUMBER : 64-47-1
LAST UPDATED : 199701
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C30-H42-N6-O4.O4-S
MOLECULAR WEIGHT : 646.84
WISWESSER LINE NOTATION : T C556 BN DNTT&J B1 D1 G1 JQ &QVM1 &QSWQ
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Eserine sulfate
* Eserine sulphate
* Physostigmine hemisulfate
* Physostigmine SO4
* Physostigmine sulfate
* Physostigmine sulphate

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Human - man
DOSE/DURATION : 191 ng/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions
Gastrointestinal - nausea or vomiting
Gastrointestinal - other changes
REFERENCE :
AEXPBL Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig,
Ger. Dem. Rep.) V.1-109, 1873-1925. For publisher information, see NSAPCC.
Volume(issue)/page/year: 53,313,1905

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,
France) V.1- 1943- Volume(issue)/page/year: 11,286,1953

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1621 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FAATDF Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1981- Volume(issue)/page/year:
4,S195,1984

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 450 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 259,153,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1680 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and
D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,137,1972

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 510 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ATXKA8 Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74.
For publisher information, see ARTODN. Volume(issue)/page/year: 29,39,1972

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil,
France) V.1- 1943- Volume(issue)/page/year: 11,286,1953

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 178 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems
Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010)
Volume(issue)/page/year: NX#03167

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1250 ug/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 44,95,1932

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 1500 ug/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 44,95,1932

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Amphibian - frog
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und
Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher
information, see NSAPCC. Volume(issue)/page/year: 207,547,1949

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Amphibian - frog
DOSE/DURATION : 325 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 44,95,1932

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - mouse
DOSE : 200 ug/kg
SEX/DURATION : female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
Reproductive - Specific Developmental Abnormalities - urogenital system
Reproductive - Effects on Newborn - sex ratio
REFERENCE :
JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc.,
2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961-
Volume(issue)/page/year: 62,1626,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Rodent - mouse
DOSE : 200 ug/kg
SEX/DURATION : female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
JPMSAE Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc.,
2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961-
Volume(issue)/page/year: 62,1626,1973

*** STATUS IN U.S. ***

EPA TSCA Section 8(b) CHEMICAL INVENTORY


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
4H-Pyrrolo(3,4-d)pyrimidin-4-one,1,6-dihydro-2,7-diphenyl-5-methyl- 57436-33-6
1H-Pyrrolo(1,2-a)indole-5,8-dione,2,3-dihydro-1-hydroxy-9-(hydroxymethyl)-7-methoxy-6-methyl-2-(methylamino)-, 9-carbamate, (E)- 62697-39-6
2H-Pyrrolo(3,4-d)pyrimidin-2-one,1,6-dihydro-4,7-diphenyl-5-methyl- 57436-09-6
4H-Pyrrolo(3,4-d)pyrimidin-4-one,1,6-dihydro-5-methyl-7-phenyl- 57436-31-4
Pyrrolo(1,2-a)pyrimidin-4-one,1,4-dihydro-1-ethyl-7-phenyl- 112466-13-4
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,5,6-dimethyl-4,7-diphenyl-1-isopropyl- 70886-89-4
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,4,5-dimethyl-1-ethyl-7-phenyl- 70886-90-7
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,4,5-dimethyl-6-ethyl-7-phenyl- 71016-55-2
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,4,7-diphenyl-1-ethyl-5-methyl- 57436-12-1
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,4,7-diphenyl-6-ethyl-5-methyl- 57436-13-2
1H-Pyrrolo(3,4-d)pyrimidin-2(3H)-one,4,7-diphenyl-3-ethyl-5-methyl-, hydrochloride 61948-13-8
6H-Pyrrolo(3,4-d)pyrimidin-2(1H)-one,4,7-diphenyl-1-isopropyl-5-methyl- 57436-15-4
1H-Pyrrolo(1,2-a)indole-5,8-dione,2,3-dihydro-1-hydroxy-9-(hydroxymethyl)-7-methoxy-6-methyl-2(methylamino)-, 9-carbamate, (Z)- 62697-40-9
Pyrrolo(1,2-a)pyrimidin-4(3H)-one,2,6,7,8-tetrahydro-6-phenyl- 76697-02-4
Pyrrolo(1,2-a)pyrimidin-4(3H)-one,2,6,7,8-tetrahydro-7-phenyl- 76696-97-4
Pyrrolo(3,4-c)pyrrole-1,3(2H,5H)-dione,5-butyl-4,6-dimethyl-2-(2-(4-phenyl-1-piperazinyl)ethyl)- 151722-70-2
Pyrrolo(3,4-c)pyrrole-1,3(2H,5H)-dione,5-butyl-4,6-dimethyl-2-(2-(4-(2-pyridinyl)-1-piperazinyl)ethyl)- 151722-71-3
Pyrrolo(3,4-c)pyrrole-1,3(2H,5H)-dione,5-butyl-4,6-dimethyl-2-(3-(4-(2-pyridinyl)-1-piperazinyl)propyl)- 151792-74-4
Pyrrolo(3,4-c)pyrrole-1,3(2H,5H)-dione,5-butyl-4,6-dimethyl-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)- 151722-78-0
Pyrrolo(2,1-b)quinazoline, 1,2,3,9-tetrahydro-,monohydrochloride 61939-05-7
Pyrrolo(2,1-b)quinazolin-3-ol, 1,2,3,9-tetrahydro- 6159-55-3
Pyrrolo(2,1-b)quinazolin-3-ol, 1,2,3,9-tetrahydro-,monohydrochloride, (R)- 7174-27-8
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,8-chloro-2,3,6,7,8,9-hexahydro-4-hydroxy-2-methyl-oxo-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester 118292-35-6
1H-Pyrrolo(1,2-a)indole-5,8-dione,2,3-dihydro-7-methoxy-9-((1-oxopropoxy)methyl)- 52531-48-3
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-4-(((4-(2-aminoethyl)-1-piperazinyl)carbonyl)oxy)-8-bromo-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1H-i ndol-2-yl) carbonyl)-, methylester 140447-61-6
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-4-(((4-(2-aminoethyl)-1-piperazinyl)carbonyl)oxy)-8-bromo-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1H-i ndol-2-yl) carbonyl)-, methylester, dihydrochloride 140447-62-7
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-4-(((1,4'-bipiperidin)-l'-ylcarbonyl)oxy)-8-bromo-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester 140447-63-8
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-4-(((1,4'-bipiperidin)-1'-ylcarbonyl)oxy)-8-bromo-2-methyl-1-oxo-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester, monohydrochloride 140447-64-9
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-8-bromo-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-1-oxo-6-((5,6,7-trimethoxy-1H-indol-2-y l)carbonyl)-, methyl ester,monohydrochloride 140447-60-5
1H-Pyrrolo(3,2-f)quinoline-2-carboxylic acid,2,3,6,7,8,9-hexahydro-8-chloro-2-methyl-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-1-oxo-6-((5,6,7-trimethoxy-1H-indol-2-y l)carbonyl)-, methyl ester,monohydrochloride 140447-71-8
3H-Pyrrolo(3,2-f)quinoline-1-carboxylic acid,6,7,8,9-tetrahydro-8-bromo-4-(((1,1-dimethylethyl)dimethylsilyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-i ndol-2-yl) carbonyl)-, methylester 140447-65-0
3H-Pyrrolo(3,2-f)quinoline-1-carboxylic acid,6,7,8,9-tetrahydro-8-chloro-4-(((1,1-dimethylethyl)dimethylsilyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbo nyl)-, methyl ester 140447-68-3
4H-Pyrrolo(3,2,1-ij)quinoline, 1,2,5,6-tetrahydro- 480-73-9
4H-Pyrrolo(3,2,1-ij)quinoline,1,2,5,6-tetrahydro-8-amino-, sulfate (2:1) (crude) 102280-97-7
Pyrrolo(2,3-b)indole,1,2,3,3a,8,8a-hexahydro-5-hydroxy-1,3a,8-trimethyl-,methylcarbamate (ester), (3aS-cis)-, sulfate (2:1) 64-47-1
3H-Pyrrolo(3,2-f)quinoline,6,7,8,9-tetrahydro-8-bromo-4-(((1,1-dimethylethyl)dimethylsilyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)- 140447-66-1
3H-Pyrrolo(3,2-f)quinoline,6,7,8,9-tetrahydro-8-chloro-4-(((1,1-dimethylethyl)dimethylsilyl)oxy)-2-methyl-6-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)- 140447-69-4
1H-Pyrrolo(2,3-f)quinoline-2,7,9-tricarboxamide,4,5-dihydro-N,N,N',N',N'',N''-hexamethyl- 4,5-dioxo- 112881-58-0
Pyrrolo(4,3,2-de)quinolinium,1,3,4,5-tetrahydro-6-hydroxy-5,5-dimethyl- 17232-69-8
6H-Pyrrolo(3,2,1-ij)quinolin-6-one,4,5-dihydro-8-chloro-2-methyl-1-phenyl- 53491-38-6
Pyrrolo(2,1-b)quinazolin-9(1H)-one,2,3-dihydro-3-hydroxy-, monohydrochloride 80039-73-2
4H-Pyrrolo(3,2,1-ij)quinolin-4-one,1,2,5,6-tetrahydro- 57369-32-1
1H-Pyrrolo(2,3-b)quinolin-4-one,2,3,4,9-tetrahydro-9-(3-dimethylaminopropyl)-1-methyl-, dihydrochloride, hydrate 74332-94-8
1H-Pyrrolo(2,3-b)quinolin-4-one,2,3,4,9-tetrahydro-1-methyl-9-(p-nitrophenacyl)- 60315-52-8
1H-Pyrrolo(2,3-b)quinol-4-one,2,3,4,9-tetrahydro-9-benzyl-1-methyl-,dihydrochloride, hydrate 102280-95-5
Pyrrolo(2,3-b)indol-5-ol,1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-,phenylcarbamate (ester), (3aS-cis)- 101246-66-6
1H-Pyrrolo(2,3-b)quinoxaline,2-(4-bromophenyl)-1-phenyl- 73040-44-5
1H-Pyrrolo(1,2,3-de)quinoxaline-6-carboxylic acid,2,3-dihydro-1-(2-(diethylamino)ethyl)-5-methyl-2-oxo-, ethyl ester,(R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) 67918-90-5
1H-Pyrrolo(2,3-b)quinoxaline,2-(4-chlorophenyl)-1-phenyl- 73040-43-4
1H-Pyrrolo(2,3-b)quinoxaline, 1,2-diphenyl- 62356-28-9

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net